Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Contralateral Prophylactic Mastectomy

Contralateral Prophylactic Mastectomy Opinion Editorials represent the opinions of the authors and JAMA EDITORIAL and not those of the American Medical Association. Is It a Reasonable Option? Lisa A. Newman, MD, MPH The professional oncology community has worked dili- seem disproportionate with their treatment needs. An gently to generate data that facilitate surgical planning and example of the former scenario is the patient with appropri- the decision-making process for patients with newly diag- ately treated ductal carcinoma in situ who develops contra- nosed breast cancer. Several lateral inflammatory breast cancer 10 years later. An lines of evidence support example of the latter scenario is the patient with a 5-mm, the importance of prioritiz- node-negative breast cancer who insists on a preference for Related article page 902 ing treatment of the known bilateral mastectomy. Did the first patient miss an opportu- cancer over and above con- nity for a life-saving CPM? Is the second patient undergoing Supplemental content at sideration of a risk-reducing unnecessary or excessive surgery? In addressing these jama.com mastectomy for the unaf- questions related to the potential benefits vs harms of CPM, fected breast (contralateral 3 stakeholders are relevant: the patient, whose concerns prophylactic mastectomy [CPM]). For example, the equiva- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Contralateral Prophylactic Mastectomy

Newman, Lisa A.
JAMA , Volume 312 (9) – Sep 3, 2014
Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/contralateral-prophylactic-mastectomy-02OI4Eqg0A

References (22)

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2014.11308
pmid
25182096
Publisher site
See Article on Publisher Site

Abstract

Opinion Editorials represent the opinions of the authors and JAMA EDITORIAL and not those of the American Medical Association. Is It a Reasonable Option? Lisa A. Newman, MD, MPH The professional oncology community has worked dili- seem disproportionate with their treatment needs. An gently to generate data that facilitate surgical planning and example of the former scenario is the patient with appropri- the decision-making process for patients with newly diag- ately treated ductal carcinoma in situ who develops contra- nosed breast cancer. Several lateral inflammatory breast cancer 10 years later. An lines of evidence support example of the latter scenario is the patient with a 5-mm, the importance of prioritiz- node-negative breast cancer who insists on a preference for Related article page 902 ing treatment of the known bilateral mastectomy. Did the first patient miss an opportu- cancer over and above con- nity for a life-saving CPM? Is the second patient undergoing Supplemental content at sideration of a risk-reducing unnecessary or excessive surgery? In addressing these jama.com mastectomy for the unaf- questions related to the potential benefits vs harms of CPM, fected breast (contralateral 3 stakeholders are relevant: the patient, whose concerns prophylactic mastectomy [CPM]). For example, the equiva-

Journal

JAMA – American Medical Association

Published: Sep 3, 2014

There are no references for this article.